Literature DB >> 17481945

Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium.

Hung-Fat Tse1, Chung-Wah Siu, Shu-Guang Zhu, Liao Songyan, Qing-Yong Zhang, Wing-Hon Lai, Yok-Lam Kwong, John Nicholls, Chu-Pak Lau.   

Abstract

OBJECTIVE: To determine the optimal bone marrow (BM) cell types, and their potential mechanisms of action for neovascularization in chronic ischaemic myocardium. METHODS AND
RESULTS: The functional effects, angiogenic potential and cytokine expression of direct intramyocardial implantation of autologous BM CD31-positive endothelial progenitor cells (EPC, n=9), BM mononuclear cells (MNCs, n=9), and saline (n=9) were compared in a swine model of chronic ischaemic myocardium. Autologous BM cells were harvested and catheter-based electromechanical mapping-guided direct intramyocardial injection was performed to target ischaemic myocardium. After 12 weeks, injection of BM-MNC resulted in significant improvements in left ventricular dP/dt (+21+/-8%, P=0.032), left ventricular pressure (+17+/-4%, P=0.048) and regional microsphere myocardial perfusion over ischaemic endocardium (+74+/-28%, P<0.05) and epicardium (+73+/-29%, P<0.05). No significant effects were observed following injection of BM-EPC or saline. Capillary density (1132+/-69 versus 903+/-44 per mm(2), P=0.047) and expression of mRNA of vascular endothelial growth factor (VEGF, 32.3+/-5.6 versus 13.1+/-3.7, P<0.05,) and angiopoietin-2 (23.9+/-3.6 versus 13.7+/-3.1, P<0.05) in ischaemic myocardium was significantly greater in the BM-MNC group than the saline group. The capillary density in ischaemic myocardium demonstrated a significant positive correlation with VEGF expression (r=0.61, P<0.001).
CONCLUSION: Catheter-based direct intramyocardial injection of BM-MNC enhanced angiogenesis more effectively than BM-EPC or saline, possibly via a paracrine effect, with increased expression of VEGF that subsequently improved cardiac performance of ischaemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481945     DOI: 10.1016/j.ejheart.2007.03.008

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  41 in total

Review 1.  Protein localization in the plant Golgi apparatus and the trans-Golgi network.

Authors:  C Saint-Jore-Dupas; V Gomord; N Paris
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

2.  Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Authors:  Ann C Gaffey; Minna H Chen; Chantel M Venkataraman; Alen Trubelja; Christopher B Rodell; Patrick V Dinh; George Hung; John W MacArthur; Renganaden V Soopan; Jason A Burdick; Pavan Atluri
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-17       Impact factor: 5.209

3.  Human skeletal muscle cells with a slow adhesion rate after isolation and an enhanced stress resistance improve function of ischemic hearts.

Authors:  Masaho Okada; Thomas R Payne; Lauren Drowley; Ron J Jankowski; Nobuo Momoi; Sarah Beckman; William C W Chen; Bradley B Keller; Kimimasa Tobita; Johnny Huard
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

Review 4.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 5.  [Surgical intramyocardial stem cell therapy for chronic ischemic heart failure].

Authors:  Alexander Kaminski; Peter Donndorf; Christian Klopsch; Gustav Steinhoff
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

6.  Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.

Authors:  R Panovsky; A Vasku; J Meluzin; M Kaminek; J Mayer; S Janousek; V Kincl; L Groch; M Navratil
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

7.  Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.

Authors:  Pavan Atluri; Jordan S Miller; Robert J Emery; George Hung; Alen Trubelja; Jeffrey E Cohen; Kelsey Lloyd; Jason Han; Ann C Gaffey; John W MacArthur; Christopher S Chen; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-28       Impact factor: 5.209

8.  Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells.

Authors:  Hirohiko Suzuki; Rei Shibata; Tetsutaro Kito; Masakazu Ishii; Ping Li; Toru Yoshikai; Naomi Nishio; Sachiko Ito; Yasushi Numaguchi; Jun K Yamashita; Toyoaki Murohara; Kenichi Isobe
Journal:  BMC Cell Biol       Date:  2010-09-22       Impact factor: 4.241

Review 9.  Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics.

Authors:  Melissa A Kinney; Tracy A Hookway; Yun Wang; Todd C McDevitt
Journal:  Ann Biomed Eng       Date:  2013-12-03       Impact factor: 3.934

10.  Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease.

Authors:  Carmen Wing-Sze Chan; Yok-Lam Kwong; Raymond Y Kwong; Chu-Pak Lau; Hung-Fat Tse
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-25       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.